Boston Scientific wins CE Mark for new defibrillation lead system

Posted on: Wed, 13 May 2009 13:17:00 EDT


Symbols: BSX
May 13, 2009 (Datamonitor via COMTEX) --
BSX | Quote | Chart | News | PowerRating -- Boston Scientific, a medical device company, has announced the CE Mark and the first human implants of the company's Endotak Reliance 4-SITE defibrillation lead system.

According to Boston Scientific, the Endotak Reliance 4-SITE lead system is designed to simplify the implant procedure by combining three terminals into one integrated connector, reducing the required implant area within the body.

This system, combined with the new Teligen implantable cardioverter defibrillator (ICD) and Cognis cardiac resynchronization therapy defibrillator (CRT-D), is designed to comply with the forthcoming international connector standard. The new standard will permit product compatibility across manufacturers, the company said.

The company is working with physicians to launch the system in several phases with a focus on monitoring clinical performance through post-market analysis enhanced by the Latitude patient management system.

Fred Colen, president of cardiac rhythm management at Boston Scientific, said: "We are pleased to announce CE Mark and the first human implants of the Endotak Reliance 4-SITE lead system. This new system represents the next advance for the Endotak Reliance lead family, which has demonstrated reliability in more than 350,000 implants worldwide."

http://www.datamonitor.com
Republication or redistribution, including by framing or similar means,
is expressly prohibited without prior written consent. Datamonitor shall
not be liable for errors or delays in the content, or for any actions
taken in reliance thereon

For full details on Boston Scientific Corp (BSX) BSX. Boston Scientific Corp (BSX) has Short Term PowerRatings at TradingMarkets. Details on Boston Scientific Corp (BSX) Short Term PowerRatings is available at This Link.

UPCOMING EVENTS
Learn new strategies, how to trade in this market, and the stocks you should be focusing on each day. Join us for our free 20 minute tele-seminars during the week.
Thursday February 11 04:30 PM
* Attendance is strictly limited and are filled on a first-come, first-served basis.